Us Bancorp \De\ Takeda Pharmaceutical CO LTD Transaction History
Us Bancorp \De\
- $78.3 Billion
- Q2 2025
A detailed history of Us Bancorp \De\ transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Us Bancorp \De\ holds 112,474 shares of TAK stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112,474
Previous 106,037
6.07%
Holding current value
$1.65 Million
Previous $1.58 Million
10.28%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding TAK
# of Institutions
374Shares Held
68.5MCall Options Held
1.69MPut Options Held
166K-
Capital Research Global Investors Los Angeles, CA13.3MShares$195 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.7MShares$83.4 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY5.32MShares$77.8 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.71MShares$54.3 Million0.54% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.43MShares$50.2 Million0.1% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $45.5B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...